Cargando…

Longitudinal brain morphology in anti-NMDA receptor encephalitis: a case report with controls

BACKGROUND: Anti-N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a severe autoimmune condition, which typically affects young females. The long-term clinical consequences and brain morphology changes after anti-NMDAR encephalitis are not well known. CASE PRESENTATION: We present clinical and n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurikainen, Heikki, Isotupa, Iina, Nyman, Mikko, Ilonen, Tuula, Nummelin, Teija, Salokangas, Raimo K. R., Hietala, Jarmo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511133/ https://www.ncbi.nlm.nih.gov/pubmed/31077184 http://dx.doi.org/10.1186/s12888-019-2141-4

Ejemplares similares

Extrapyramidal symptoms predict cognitive performance after first-episode psychosis
por: Lindgren, Maija, et al.
Publicado: (2022)

S170. AMYGDALA SUBNUCLEI VOLUMES IN FIRST-EPISODE PSYCHOSIS: ASSOCIATION WITH CHILDHOOD ADVERSITY
por: Armio, Reetta-Liina, et al.
Publicado: (2018)

S132. SAMPLING BIAS IN STUDIES OF FIRST-EPISODE PSYCHOSIS – A FOLLOW-UP STUDY
por: Walta, Maija, et al.
Publicado: (2020)

Sense of mastery in first-episode psychosis—a one-year follow-up study
por: Lindgren, Maija, et al.
Publicado: (2023)

Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS)
por: Salokangas, Raimo K. R., et al.
Publicado: (2021)

Onset Age of Substance Use and Neuropsychological Performance in Hospital Patients
por: Höijer, Irma, et al.
Publicado: (2020)

Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function
por: Laurikainen, Heikki, et al.
Publicado: (2020)

F135. BODY MASS INDEX TRAJECTORIES IN CHILDHOOD AND RISK FOR NON-AFFECTIVE PSYCHOSIS – A GENERAL POPULATION COHORT STUDY
por: Sormunen, Elina, et al.
Publicado: (2018)

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

Anti-NMDA Receptor Encephalitis and Vaccination
por: Wang, Hsiuying
Publicado: (2017)

Anti-NMDA-receptor antibody encephalitis in infants
por: Matoq, Amr A., et al.
Publicado: (2015)

Pediatric anti-NMDA receptor encephalitis is seasonal
por: Adang, Laura A, et al.
Publicado: (2014)

Catatonic Syndrome in Anti-NMDA Receptor Encephalitis
por: Mythri, Starlin Vijay, et al.
Publicado: (2016)

Two Cases of Anti-NMDA Receptor Encephalitis
por: Baker, Jessa, et al.
Publicado: (2016)

Balint syndrome in anti-NMDA receptor encephalitis
por: Metzger, Aude, et al.
Publicado: (2018)

Paraneoplastic anti-NMDA receptor encephalitis in 1830?
por: Tényi, Dalma, et al.
Publicado: (2020)

Neurocritical care for Anti-NMDA receptor encephalitis
por: Lin, Kuang-Lin, et al.
Publicado: (2020)

Psychiatric Presentation of Anti-NMDA Receptor Encephalitis
por: Endres, Dominique, et al.
Publicado: (2019)

ANTI-NMDA-R encephalitis: case report
por: Tosunoğlu, Bünyamin, et al.
Publicado: (2022)

Anti-NMDA Receptor Encephalitis or Psychiatric disorder?
por: Freitas, B., et al.
Publicado: (2022)

Metabolic trajectories in childhood and adolescence: Effects on risk for schizophrenia
por: Sormunen, Elina, et al.
Publicado: (2022)

Aberrant multimodal brain networks in patients with anti‐NMDA receptor encephalitis
por: Wang, Jinhui, et al.
Publicado: (2021)

Anti-NMDA Receptor Encephalitis in a Pregnant Woman
por: Kim, Jiyoung, et al.
Publicado: (2015)

A case report: anti-NMDA receptor encephalitis
por: Bhat, Pavan, et al.
Publicado: (2018)

Multifocal Stroke Complicating Anti-NMDA Receptor Encephalitis
por: Stavitsky, Zina H., et al.
Publicado: (2020)

Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis
por: Wang, Wei, et al.
Publicado: (2020)

Anesthetic care for patients with anti-NMDA receptor encephalitis
por: Al Ghamdi, Faris, et al.
Publicado: (2020)

Anti-NMDA receptor encephalitis: A case report
por: Tan, H.L.
Publicado: (2021)

Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis
por: Gable, M. S., et al.
Publicado: (2009)

The neural and molecular basis of working memory function in psychosis: a multimodal PET-fMRI study
por: Borgan, Faith, et al.
Publicado: (2019)

Anaesthetic management of a patient with anti-NMDA receptor encephalitis
por: Shaikh, Mohammed Aslam, et al.
Publicado: (2015)

Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection
por: Salovin, Amy, et al.
Publicado: (2018)

Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017)

Anti-NMDA-R encephalitis: follow-up of 24 months
por: Soares, Emilia Maria Veloso, et al.
Publicado: (2013)

Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis
por: Shin, Yong‐Won, et al.
Publicado: (2018)

Anti-NMDA receptor encephalitis: epidemiological differences and common challenges
por: Ceanga, Mihai, et al.
Publicado: (2020)

Subacute Sclerosing Panencephalits Mimicking Anti-NMDA Receptor Encephalitis
por: Devamare, Shilpa, et al.
Publicado: (2020)

Early Bortezomib Therapy for Refractory Anti-NMDA Receptor Encephalitis
por: Turnbull, Marion T., et al.
Publicado: (2020)

Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series
por: Joubert, Bastien, et al.
Publicado: (2020)

Pediatric anti-NMDA receptor encephalitis associated with COVID-19
por: Sarigecili, Esra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a4v20hvu4q51u4f82m337s4fmr